Close

This is a StreetInsider.com Premium Only Page

Please sign-up to enjoy all the benefits of StreetInsider.com Premium or log-in if you're already a member.

Send to a Friend Font Size: Increase Decrease

Back to LXRX Stock Lookup

Lexicon Pharma (LXRX) – Litigation

Dec 2, 2019 07:59 AM Lexicon Pharma (LXRX) says FDA reiterated prior position and denied its appeal of CRL in relation to NDA for sotagliflozin in type 1 diabetes

Back to LXRX Stock Lookup